A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Doctors caution that successful outcomes could depend on how early patients are referred to a specialist for advanced therapies.
New research suggests LVADs may not solve mitral regurgitation for some patients with poor right heart function.
A team of researchers are looking at all angles to figure out how to reduce the rates of health-care-associated infections for patients who get ventricular assist devices.
Recent approval from the FDA for HeartMate 3 opens the door to an important option for people with advanced heart failure.